Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway

Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway

Abstract Background Radiotherapy plays an important role in the treatment of prostate cancer. Despite that sophisticated techniques of radiotherapy and radiation combined with chemotherapy were applied to the patients, some tumors may recur. Therefore, the study investigated the effect of dihydroiso...

Full description

Bibliographic Details
Main Authors: I-Yun Lee, Yin-Yin Lin, Yao-Hsu Yang, Yu-Shin Lin, Chun-Liang Lin, Wei-Yu Lin, Yu-Ching Cheng, Li-Hsin Shu, Ching-Yuan Wu
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Pharmacology and Toxicology
Subjects:
Dihydroisotanshinone I
Radiosensitive
Prostate cancer
DNA damage
CCL2
Online Access:http://link.springer.com/article/10.1186/s40360-018-0195-4

Internet

http://link.springer.com/article/10.1186/s40360-018-0195-4

Similar Items